- REPORT SUMMARY
- TABLE OF CONTENTS
-
The worldwide Drug Discovery market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 10.6% during the forecast period.
This report presents the market size and development trends by detailing the Drug Discovery market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Drug Discovery market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Drug Discovery industry and will help you to build a panoramic view of the industrial development.
Drug Discovery Market, By Type:
Drug Metabolism and Pharmacokinetics (DMPK) Services
Pharmaceutical Services
Chemical Services
Biological Services
Drug Discovery Market, By Application:
Research Institutes
Pharmaceutical Companies
Biotechnology Companies
Others
Some of the leading players are as follows:
Glaxosmithkline LLC
AMRI Global
Eli Lily
Eli Lilly and Company
Boehringer Ingelheim, INC
Merck & Co.
GenScript
Viva Biotech (Shanghai) Ltd.
Pfizer
WIL Research Laboratories
Covance
Sanofi
Johnson and Johnson
Evotec A.G.
IQVIA
Gilead Sciences Inc
Genome Biologics
Roche Holding AG
Geographically, Major regions are analyzed in details are as follows:
-
North America
-
Europe
-
Asia Pacific
-
Latin America
-
Middle East & Africa
Table of Contents
1 Methodology and Scope
-
1.1 Market Segmentation & Scope
-
1.1.1 Technology Type
-
1.1.2 Product
-
1.1.3 Application
-
1.1.4 Regional scope
-
1.1.5 Estimates and forecast timeline
-
1.2 Research Methodology
-
1.3 Information Procurement
-
1.3.1 Purchased database
-
1.3.2 Internal database
-
1.3.3 Secondary sources
-
1.3.4 Primary research
-
1.3.5 Details of primary research
-
1.4 Information or Data Analysis
-
1.4.1 Data analysis models
-
1.5 Market Formulation & Validation
-
1.6 Model Details
-
1.6.1 Commodity flow analysis
-
1.6.2 Volume price analysis
-
1.7 List of Secondary Sources
-
1.8 List of Abbreviations
2 Executive Summary
-
2.1 Market Outlook
-
2.2 Segment Outlook
3 Market Variables, Trends, & Scope
-
3.1 Market Lineage Outlook
-
3.1.1 Parent market outlook
-
3.1.2 Ancillary market outlook
-
3.2 Market Segmentation
-
3.2.1 Analysis
-
3.3 Market Dynamics
-
3.3.1 Market driver analysis
-
3.3.2 Market restraint analysis
-
3.3.3 Industry opportunities
-
3.4 Penetration & Growth Prospect Mapping
-
3.4.1 Penetration & growth prospect mapping analysis
-
3.5 Business Environment Analysis Tools
-
3.5.1 Porter's five forces analysis
-
3.5.2 PESTLE analysis
-
3.5.3 Major deals & strategic alliances analysis
4 Drug Discovery Market: Technology Type Analysis
-
4.1 Drug Discovery Technology Type Market Share Analysis, 2018 & 2026
-
4.2 Drug Discovery Technology Type Market: Segment Dashboard
-
4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment
4.3.1 Drug Metabolism and Pharmacokinetics (DMPK) Services
4.3.2 Pharmaceutical Services
4.3.3 Chemical Services
4.3.4 Biological Services
5 Drug Discovery Market: Product Analysis
-
5.1 Drug Discovery Product Market Share Analysis, 2018 & 2026
-
5.2 Drug Discovery Product Market: Segment Dashboard
-
5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment
6 Drug Discovery Market: Application Analysis
-
6.1 Drug Discovery Application Market Share Analysis, 2018 & 2026
-
6.2 Drug Discovery Application Market: Segment Dashboard
-
6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment
6.3.1 Research Institutes
6.3.2 Pharmaceutical Companies
6.3.3 Biotechnology Companies
6.3.4 Others
7 Drug Discovery Market: Regional Analysis
-
7.1 Drug Discovery Regional Market Share Analysis, 2018 & 2026
-
7.2 Drug Discovery Regional Market: Segment Dashboard
-
7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)
-
7.4 List of Players at Regional Level
-
7.4.1 North America
-
7.4.2 Europe
-
7.4.3 Asia Pacific
-
7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
-
7.5.1 North America
-
7.5.2 Europe
-
7.5.3 Asia Pacific
-
7.5.4 Latin America
-
7.5.5 MEA
-
7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026
-
7.6.1 North America
-
7.6.2 Europe
-
7.6.3 Asia Pacific
-
7.6.4 Latin America
-
7.6.5 Middle East & Africa
8 Competitive Analysis
-
8.1 Recent Developments & Impact Analysis, by Key Market Participants
-
8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)
-
8.3 Vendor Landscape
-
8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)
9 Company Profiles
9.1 Glaxosmithkline LLC
9.1.1 Glaxosmithkline LLC Company overview
9.1.2 Financial performance
9.1.3 Product benchmarking
9.1.4 Strategic initiatives
9.1.5 SWOT analysis
9.2 AMRI Global
9.2.1 AMRI Global Company overview
9.2.2 Financial performance
9.2.3 Product benchmarking
9.2.4 Strategic initiatives
9.2.5 SWOT analysis
9.3 Eli Lily
9.3.1 Eli Lily Company overview
9.3.2 Financial performance
9.3.3 Product benchmarking
9.3.4 Strategic initiatives
9.3.5 SWOT analysis
9.4 Eli Lilly and Company
9.4.1 Eli Lilly and Company Company overview
9.4.2 Financial performance
9.4.3 Product benchmarking
9.4.4 Strategic initiatives
9.4.5 SWOT analysis
9.5 Boehringer Ingelheim, INC
9.5.1 Boehringer Ingelheim, INC Company overview
9.5.2 Financial performance
9.5.3 Product benchmarking
9.5.4 Strategic initiatives
9.5.5 SWOT analysis
9.6 Merck & Co.
9.6.1 Merck & Co. Company overview
9.6.2 Financial performance
9.6.3 Product benchmarking
9.6.4 Strategic initiatives
9.6.5 SWOT analysis
9.7 GenScript
9.7.1 GenScript Company overview
9.7.2 Financial performance
9.7.3 Product benchmarking
9.7.4 Strategic initiatives
9.7.5 SWOT analysis
9.8 Viva Biotech (Shanghai) Ltd.
9.8.1 Viva Biotech (Shanghai) Ltd. Company overview
9.8.2 Financial performance
9.8.3 Product benchmarking
9.8.4 Strategic initiatives
9.8.5 SWOT analysis
9.9 Pfizer
9.9.1 Pfizer Company overview
9.9.2 Financial performance
9.9.3 Product benchmarking
9.9.4 Strategic initiatives
9.9.5 SWOT analysis
9.10 WIL Research Laboratories
9.10.1 WIL Research Laboratories Company overview
9.10.2 Financial performance
9.10.3 Product benchmarking
9.10.4 Strategic initiatives
9.10.5 SWOT analysis
9.11 Covance
9.11.1 Covance Company overview
9.11.2 Financial performance
9.11.3 Product benchmarking
9.11.4 Strategic initiatives
9.11.5 SWOT analysis
9.12 Sanofi
9.12.1 Sanofi Company overview
9.12.2 Financial performance
9.12.3 Product benchmarking
9.12.4 Strategic initiatives
9.12.5 SWOT analysis
9.13 Johnson and Johnson
9.13.1 Johnson and Johnson Company overview
9.13.2 Financial performance
9.13.3 Product benchmarking
9.13.4 Strategic initiatives
9.13.5 SWOT analysis
9.14 Evotec A.G.
9.14.1 Evotec A.G. Company overview
9.14.2 Financial performance
9.14.3 Product benchmarking
9.14.4 Strategic initiatives
9.14.5 SWOT analysis
9.15 IQVIA
9.15.1 IQVIA Company overview
9.15.2 Financial performance
9.15.3 Product benchmarking
9.15.4 Strategic initiatives
9.15.5 SWOT analysis
9.16 Gilead Sciences Inc
9.16.1 Gilead Sciences Inc Company overview
9.16.2 Financial performance
9.16.3 Product benchmarking
9.16.4 Strategic initiatives
9.16.5 SWOT analysis
9.17 Genome Biologics
9.17.1 Genome Biologics Company overview
9.17.2 Financial performance
9.17.3 Product benchmarking
9.17.4 Strategic initiatives
9.17.5 SWOT analysis
9.18 Roche Holding AG
9.18.1 Roche Holding AG Company overview
9.18.2 Financial performance
9.18.3 Product benchmarking
9.18.4 Strategic initiatives
9.18.5 SWOT analysis
The List of Tables and Figures (Totals 112 Figures and 147 Tables)
Figure Drug Metabolism and Pharmacokinetics (DMPK) Services Drug Discovery market, 2015 - 2026 (USD Million)
Figure Pharmaceutical Services Drug Discovery market, 2015 - 2026 (USD Million)
Figure Chemical Services Drug Discovery market, 2015 - 2026 (USD Million)
Figure Biological Services Drug Discovery market, 2015 - 2026 (USD Million)
Figure Research Institutes market, 2015 - 2026 (USD Million)
Figure Pharmaceutical Companies market, 2015 - 2026 (USD Million)
Figure Biotechnology Companies market, 2015 - 2026 (USD Million)
Figure Others market, 2015 - 2026 (USD Million)
-
Table List of players in North America
-
Table List of players in Europe
-
Table List of players in Asia Pacific
-
Table SWOT analysis
-
Table North America Drug Discovery market, by country, 2015 - 2026 (USD Million)
-
Table North America Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table North America Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table North America Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.S. Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table U.S. Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table U.S. Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Canada Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Canada Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Canada Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Europe Drug Discovery market, by country, 2015 - 2026 (USD Million)
-
Table Europe Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Europe Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Europe Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table U.K. Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table U.K. Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table U.K. Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Germany Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Germany Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Germany Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table France Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table France Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table France Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Italy Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Italy Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Italy Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Spain Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Spain Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Spain Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Asia Pacific Drug Discovery market, by country, 2015 - 2026 (USD Million)
-
Table Asia Pacific Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Asia Pacific Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Asia Pacific Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table China Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table China Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table China Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Japan Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Japan Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Japan Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table India Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table India Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table India Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Latin America Drug Discovery market, by country, 2015 - 2026 (USD Million)
-
Table Latin America Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Latin America Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Latin America Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Brazil Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Brazil Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Brazil Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Mexico Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Mexico Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Mexico Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Argentina Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Argentina Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Argentina Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table MEA Drug Discovery market, by country, 2015 - 2026 (USD Million)
-
Table MEA Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table MEA Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table MEA Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table South Africa Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table South Africa Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table South Africa Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Regulatory scenario
-
Table Nigeria Drug Discovery market, by type, 2015 - 2026 (USD Million)
-
Table Nigeria Drug Discovery market, by product, 2015 - 2026 (USD Million)
-
Table Nigeria Drug Discovery market, by application, 2015 - 2026 (USD Million)
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Recent Developments & Impact Analysis, by Key Market Participants
-
Table Company market position analysis
Table Company Profiles
Table Glaxosmithkline LLC Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table AMRI Global Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lily Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Eli Lilly and Company Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Boehringer Ingelheim, INC Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Merck & Co. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table GenScript Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Viva Biotech (Shanghai) Ltd. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Pfizer Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table WIL Research Laboratories Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Covance Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Sanofi Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Johnson and Johnson Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Evotec A.G. Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table IQVIA Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Gilead Sciences Inc Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Genome Biologics Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
Table Company Profiles
Table Roche Holding AG Production, Value, Price, Gross Margin 2014-2019
Table Product benchmarking
Table Strategic initiatives
Table SWOT analysis
-